Classical Swine Fever live vaccine approved in China Classical Swine Fever live vaccine approved in China Boehringer Ingelheim’s China-developed Classical Swine Fever live vaccine approved
Vetera Vetera For vaccination of healthy horses as an aid in the prevention of diseases caused by the included antigens (US and Canada only).
Soaring to save lives Soaring to save lives Tackling health disparities through drone delivery of vaccines animals and livestock living in underserved communities
Reduction of Salmonella in swine after vaccination Reduction of Salmonella in swine after vaccination Authorities acknowledge reduction of Salmonella after vaccination with Enterisol® Ileitis
A Unique Bond: friends in need A Unique Bond: friends in need After suffering from a stroke, Phil’s connection with Valle helped change his life
Action makes the difference in poultry farms Action makes the difference in poultry farms Farmers, be on the lookout to protect chickens against the ILT virus!
NexGard Spectra NexGard Spectra Prevents heartworm disease and treats and controls hookworm, roundworm, whipworm, and lungworm infestations in dogs and puppies.
Our-position Our-position Potential access to selected medications for appropriate patients with serious, life-threatening diseases unable to participate in a clinical trial
2024 half year results innovation progress 2024 half year results innovation progress First half of 2024: Boehringer Ingelheim progresses pipeline at pace and reaches major milestones
Boehringer Ingelheim and Fraunhofer partnership Boehringer Ingelheim and Fraunhofer partnership Boehringer Ingelheim and Fraunhofer IME launch collaboration which aims to develop sustainable animal health products
Boehringer Ingelheim good 2021 business performance Boehringer Ingelheim good 2021 business performance 2021 was a good year for patients, for animal owners and for Boehringer Ingelheim.
Winners of the 2020 European PRRS Research Award Winners of the 2020 European PRRS Research Award Winners of the 2020 European PRRS Research Award announced Three winner awarded 25,000 euro each for their research.
Lamb-shanks video Lamb-shanks video This succulent, heart dish is packed full of flavour and sure to be a hit with the whole family.
Prascend Prascend Symptomatic treatment of clinical signs associated with pituitary pars intermedia dysfunction (PPID; also known as equine Cushing’s disease).
Winners of 2020 BVDzero Case Awards Winners of 2020 BVDzero Case Awards Winners of 2020 BVDzero Case Awards announced. 10 top clinical cases will receive a total prize of 15,000 euros.
Boehringer Ingelheim acquires Global Stem cell Technology Boehringer Ingelheim acquires Global Stem cell Technology Boehringer Ingelheim acquires Global Stem cell Technology, Belgian veterinary biotech company, to strengthen its stem cell capabilities in Animal Health
Advancing health equity for rural doctors in Mexico Advancing health equity for rural doctors in Mexico Our virtual sales team helps doctors stay informed through digital education about the latest treatments, regardless of their location
InSensitive Content: impact on the GPP patient community InSensitive Content: impact on the GPP patient community Understand why the patient community should be able to post and consume visual content related to generalized pustular psoriasis.
Retinal Health: Meet the Scientists Retinal Health: Meet the Scientists We aim to prevent, treat, and restore vision loss. Delve behind the lab to see our scientists spearheading research to address retinopathies.
Behind the Lab Behind the Lab Delve behind the lab to see how our Retinal Health scientists are spearheading research into novel therapeutics to treat retinopathies.
Boehringer Ingelheim partners with PetMedix Boehringer Ingelheim partners with PetMedix Partnering with PetMedix on Ky9™ platform cutting edge technology as a means to bring innovative new therapies to improve health of animals
NexGard COMBO for cats EMA marketing authorization NexGard COMBO for cats EMA marketing authorization Boehringer Ingelheim received marketing authorization from the EMA (European Medicine Agency) for its NexGard® COMBO topical solution for cats.